Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older, of any gender
- People who have been newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia (a specific type of blood cancer identified by certain genetic markers)
- People whose cancer cells carry a protein on their surface called CD19
- People whose doctors expect them to survive for more than 3 months
- People whose liver, kidneys, pancreas, and heart are functioning at adequate levels, based on specific blood test results and a heart scan (confirm with trial site for exact values)
- People who are willing and able to give written consent before any screening procedures begin
Who may not be able to join:
- People whose condition is a form of chronic myelocytic leukemia (CML) that has transformed into a lymphoid blast crisis, rather than a true acute lymphoblastic leukemia
- People who have already received or are currently receiving treatment for acute lymphoblastic leukemia (such as targeted therapy drugs or radiation), with the exception of certain approved pre-treatments
- People who have had a heart attack in the past 12 months, or who have significant heart problems such as unstable chest pain, heart failure, uncontrolled high blood pressure, or uncontrolled irregular heartbeat
- People with a serious active infection that is not under control and may interfere with treatment, in the opinion of the medical team
- People known to be HIV positive
- People who have had acute pancreatitis (inflammation of the pancreas) within the past year, or who have chronic pancreatitis
- People with very high levels of triglycerides (a type of fat) in their blood that are not under control
- People who have been diagnosed and treated for another type of cancer within the past 5 years, or who have any remaining signs of a previously diagnosed cancer — though people with certain completely removed skin cancers or non-spreading cancers may still be eligible (confirm with trial site)
- People who are pregnant or breastfeeding
- People with signs that the leukemia has spread to the brain, spinal cord, or other areas outside the bone marrow
- People with poorly controlled diabetes, based on a blood sugar control test result above a certain level — though people with well-managed diabetes may still be eligible
- People with serious psychiatric conditions that, in the opinion of the medical team, may interfere with completing treatment
- People whom the investigators consider unsuitable for the study for other medical reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jianxiang Wang, Dr, Institute of Hematology & Blood Diseases Hospital, China
Phone: 86-22-23608451
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease-free Survival (DFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.